title: Single dose i.v. tropisetron in the prevention of postoperative nausea and vomiting after gynaecological surgery.
abstract: In a prospective, randomized, multicentre, double-blind, placebo-controlled study, we have compared the efficacy of a single i.v. dose of tropisetron 0.5 mg, 2 mg and 5 mg in the prevention of postoperative nausea and vomiting (PONV). We studied 385 ASA class I and II female patients undergoing abdominal or vaginal gynaecological surgery, including laparoscopy. Tropisetron or placebo were administered before a standardized general anaesthetic. The frequency of vomiting in the 24-h period after entry into the recovery room was reduced from 44% after placebo to 31%, 26% and 30% after tropisetron 0.5 mg, 2 mg and 5 mg, respectively (P = 0.06, P = 0.009 and P = 0.043; unadjusted). Compared with placebo, nausea was reduced from 55% to 46%, 34% and 46% (P = 0.25, P = 0.003, P = 0.22), and need for rescue treatment from 39% to 29%, 23% and 35% (P = 0.13, P = 0.017 and P = 0.59) for the same groups. Tropisetron 2 mg appeared to be the optimal dose for prophylaxis against PONV with a side-effect profile similar to that of placebo.
authors.affiliation: Centre Hospitalier Universitaire Vésale, Montigny-le-Tilleul, Belgium.
authors.forename: V
authors.initials: V
authors.lastname: Capouet
authors.forename: C
authors.initials: C
authors.lastname: De Pauw
authors.forename: B
authors.initials: B
authors.lastname: Vernet
authors.forename: D
authors.initials: D
authors.lastname: Ivens
authors.forename: V
authors.initials: V
authors.lastname: Derijcke
authors.forename: L
authors.initials: L
authors.lastname: Versichelen
authors.forename: H
authors.initials: H
authors.lastname: van Aken
authors.forename: B
authors.initials: B
authors.lastname: Ickx
authors.forename: L
authors.initials: L
authors.lastname: Ritter
authors.forename: F
authors.initials: F
authors.lastname: Hulstaert
mesh_terms: D000328:Adult; D000368:Aged; D000762:Anesthesia Recovery Period; D000932:Antiemetics / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D005836:Genitalia, Female / Q000601:surgery*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000009:adverse effects; D007275:Injections, Intravenous; D008875:Middle Aged; D009325:Nausea / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D012702:Serotonin Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000077526:Tropisetron; D014839:Vomiting / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D007211:Indoles; D012702:Serotonin Antagonists; D000077526:Tropisetron